Tauro.I spoke to management the other day regarding their recent results on NNZ2591 .It is fair to say that they were extremely pleased with the results .It is my impression that a lot more positive results for other indications will come over time .I have no doubt that Acadia Pharmaceuticals will be watching developments closely .
Ann: Validation for NNZ-2591 neurodevelopmental disorder pipeline, page-76
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.65 |
Change
-0.050(0.30%) |
Mkt cap ! $2.098B | |||
| Open | High | Low | Value | Volume |
| $16.68 | $16.86 | $16.51 | $3.175M | 190.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 174 | $16.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.66 | 1971 | 15 |
View Market Depth
| Last trade - 15.42pm 30/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |